Abstract
Cranial neuralgias are paroxysmal painful disorders of the head characterised by some shared features such as unilaterality of symptoms, transience and recurrence of attacks, superficial and “shock-like” quality of pain and the presence of triggering factors. Although rare, these disorders must be promptly recognised as they harbour a relatively high risk for underlying compressive or inflammatory disease. Nevertheless, misdiagnosis is frequent. Trigeminal and glossopharyngeal neuralgias are sustained in most cases by a neurovascular conflict in the posterior fossa resulting in a hyperexcitability state of the trigeminal circuitry. If the aetiology of trigeminal neuralgia (TN) and other typical neuralgias must be brought back to the peripheral injury, their pathogenesis could involve central allodynic mechanisms, which, in patients with inter-critical pain, also engage the nociceptive neurons at the thalamic-cortical level. Currently available medical treatments for TN and other cranial neuralgias are reviewed.
Similar content being viewed by others
References
Headache Classification Subcommittee of the International Headache Society (2004). The International Classification of Headache Disorders, 2nd edition. Cephalalgia 24[Suppl 1]:9–160
Katusic S, Williams DB, Beard CM et al (1991) Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences. Neuroepidemiology 10:276–281
MacDonald BK, Cockerel OC, Sander JW (2000) The incidence and lifetime prevalence of neurological disorders in a community based study in UK. Brain 123:665–676
Hooge JP, Redekop WK (1995) Trigeminal neuralgia in multiple sclerosis. Neurology 45:1294–1296
De Simone R, Marano E, Brescia Morra V et al (2005) A clinical comparison of trigeminal neuralgic pain in patients with and without underlying multiple sclerosis. Neurol Sci 26:S150–S151
Rozen TD (2004) Trigeminal Neuralgia and glossopharyngeal neuralgia. Neurol Clin Am 22:185–206
Smyth P, Greenough G, Stommel E (2003) Familial trigeminal neuralgia: case reports and review of the literature. Headache 43:910–915
Savica R, Laganà A, Siracusano R et al (2007) Idiopathic familial trigeminal neuralgia: a case report. Neurol Sci 28:196–198
Scrivani SJ, Keith DA, Kulich R et al (1998) Posttraumatic gustatory neuralgia: a clinical model of trigeminal neuropathic pain. J Orofac Pain 12:287–292
Goadsby PJ, Matharu MS, Boes CJ (2001) SUNCT syndrome or trigeminal neuralgia with lacrimation. Cephalalgia 21:82–83
Evans WR, Bassiur JP (2005) Pretrigeminal neuralgia. Headache 45:242–244
Rushton JG, MacDonald HN (1957) Trigeminal neuralgia. Special considerations of nonsurgical treatment. JAMA 165:437–440
Cheng TM, Cascino TL, Onofrio BM (1993) Comprehensive study of diagnosis and treatment of trigeminal neuralgia secondary to tumors. Neurology 43:2298–2302
Obermann M, Yoon MS, Ese D et al (2007) Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia. Neurology 69:835–841
Burchiel KJ, Slavin KV (2000) On the natural history of trigeminal neuralgia. Neurosurgery 46:152–155
Manzoni GC. Torelli P (2005) Epidemiology of typical and atypical craniofacial neuralgias. Neurol Sci 26[Suppl 2]:s65–67
Coffey RJ, Fromm GH (1991) Familial trigeminal neuralgia and Charcot-Marie-Tooth neuropathy. Report of two families and review. Surg Neurol 35:49–53
Cruccu G, Biasiotta A, Galeotti F et al (2006) Diagnostic accuracy of trigeminal reflex testing in trigeminal neuralgia. Neurology 66:139–141
Rushton JG, Stevens JC, Miller RH (1981) Glossopharyngeal (vagoglossopharyngeal) neuralgia. A study of 217 cases. Arch Neurol 38:201–205
Bruyn GW (1983) Glossopharyngeal neuralgia. Cephalalgia 3:143–157
Montalbetti L, Ferrandi D, Pergami P, Savoldi F (1995) Elongated styloid process and Eagle’s syndrome. Cephalalgia 15:80–93
Bruyn GW (1984) Nervus intermedius neuralgia (Hunt). Cephalalgia 4:71–78
Kuhn WF, Kuhn SC, Gilberstadt H (1997) Occipital neuralgias: clinical recognition of a complicated headache. A case series and literature review. J Orofac Pain 11:158–165
Tancredi A, Caputi F (2004) Greater occipital neuralgia and arthrosis of C1-2 lateral joint. Eur J Neurol 11:573–574
Bruyn GW (1983) Superior laryngeal neuralgia. Cephalalgia 3:235–240
Jannetta PJ (1967) Arterial compression of the trigeminal nerve at the pons in patients with trigeminal neuralgia. J Neurosurg 26[Suppl]:159–162
Boecher-Schwarz HG, Bruehl K, Kessel G (1998) Sensitivity and specificity of MRA in the diagnosis of neurovascular compression in patients with trigeminal neuralgia. A correlation of MRA and surgical findings. Neuroradiology 40:88–95
Barker FG, Jannette PJ, Bissonette DJ et al (1996) The longterm outcome of microvascular decompression for trigeminal neuralgia. N Engl J Med 334:1077–1183
Leandri M, Eldridge P, Miles J (1998) Recovery of nerve conduction following microvascular decompression for trigeminal neuralgia. Neurology 51:1641–1646
Miles JB, Eldridge PR, Haggett CE, Bowsher D (1997) Sensory effects of microvascular decompression in trigeminal neuralgia. J Neurosurg 86:193–196
Cruccu G, Leandri M, Feliciani M, Manfredi M (1990) Idiopathic and symptomatic trigeminal pain. J Neurol Neurosurg Psychiatry 53:1034–1042
MarinkoviĆ S, TodoroviĆ V, Gibo H et al (2007) The trigeminal vasculature pathology in patients with neuralgia. Headache 47:1334–1339
Burchiel KJ (1980) Abnormal impulse generation in focally demyelinated trigeminal roots. J Neurosurg 53:674–683
Bennetto L, Patel NK, Fuller G (2007) Trigeminal neuralgia and its management. BMJ 334:201–205
Love S, Terry Gradidge T, Coakham HB (2001) Trigeminal neuralgia due to multiple sclerosis: ultrastructural findings in trigeminal rhizotomy specimens. Neuropathol Appl Neurobiol 27:238–244
Gass A, Kitchen N, MacManus DG et al (1997) Trigeminal neuralgia in patients with multiple sclerosis: lesion localization with magnetic resonance imaging. Neurology 49:1142–1144
Rappaport ZH, Govrin-Lippmann R, Devor M (1997) An electronmicroscopic analysis of biopsy samples of the trigeminal root taken during microvascular decompressive surgery. Stereotact Funct Neurosurg 68:182–186
Nurmikko TJ, Eldridge PR (2001) Trigeminal neuralgia pathophysiology, diagnosis and current treatment. Br J Anaesth 87:117–132
Adams CBT (1989) Microvascular compression: an alternative view and hypothesis. J Neurosurg 57:1–12
Hamlyn PJ, King TJ (1992) Neurovascular compression in trigeminal neuralgia: a clinical and anatomical study. J Neurosurg 76:948–952
Sindou M, Leston J, Howeidy T et al (2006) Micro-vascular decompression for primary Trigeminal Neuralgia (typical or atypical). Long-term effectiveness on pain; prospective study with survival analysis in a consecutive series of 362 patients. Acta Neurochir (Wien) 148:1235–1245
Fromm GH (1991) Pathophysiology of trigeminal neuralgia. In: Fromm GH, Sessle BJ (eds) Trigeminal Neuralgia: current concepts regarding pathogenesis and treatment. Butterworth-Heinemann, Boston, pp 105–130
Szapiro J, Sindou M (1985) Prognostic factors in microvascular decompression for trigeminal neuralgia. Neurosurgery 17:920–929
Amir R, Devor M (2000) Functional cross-excitation between afferent A-and C-neurons in dorsal root ganglia. Neuroscience 95:189–195
Amir R, Devor M (1996) Chemically mediated cross-excitation in rat dorsal root ganglia. J Neurosci 16:4733–4741
Amir R, Michaelis M, Devor M (1999) Membrane potential oscillations in dorsal root ganglion neurons: role in normal electrogenesis and neuropathic pain. J Neurosci 19:8589–8596
Kerr FWL (1967) Pathology of trigeminal neuralgia: light and electron microscopic observations. J Neurosurg 26:151–156
Beaver DL (1967) Electron microscopy of the Gasserian ganglion in trigeminal neuralgia. J Neurosurg 26:138–150
Kanai A, Saito M, Hoka S (2006) Subcutaneous sumatriptan for refractory trigeminal neuralgia. Headache 46:577–582.
Argoff CE (2002) A focused review on the use of botulinum toxins for neuropathic pain. Clin J Pain 18[Suppl 6]:S177–S181
Aoki KR (2005) Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 26:785–793
Wiffen PJ, McQuay HJ, Moore RA (2005) Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev (3):CD005451
Rappaport ZH, Devor M (1994) Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion. Pain 56:127–138
Backonja MM (2002) Use of anticonvulsants for treatment of neuropathic pain. Neurology 59:S14–S17
Taylor JC, Brauer S, Espir LE (1981) Long-term treatment of trigeminal neuralgia with carbamazepine. Postgrad Med J 5:16–18
Pellock JM (1987) Carbamazepine side effects in children and adults. Epilepsia 28:S64–S70
Zakrzewska JM, Lopez BC (2005) Trigeminal neuralgia. Clin Evid: 1669–1677
Canavero S, Bonicalzi V (2006) Drug therapy of trigeminal neuralgia. Expert Rev Neurother 6:429–440
Raskin NH (1988) Facial pain. In: Headache. New York: Churchill Livingstone:333–374.
Wiffen PJ, McQuay HJ, Edwards JE, Moore RA (2005) Gabapentin for acute and chronic pain. Cochrane Database Syst Rev (3:CD005452
Obermann M, Yoon MS, Sensen K et al (2007) Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia 28:174–181
Zakrzewska JM, Chaudhry Z, Nurmikko TJ et al (1997) Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind, placebo-controlled, crossover trial. Pain 73:223–230
Lunardi G, Leandri M, Albano C et al (1997) Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 48:1714–1717
Gilron I, Booher SL, Rowan JS, Max MB (2001) Topiramate in trigeminal neuralgia: a randomized, placebo-controlled multiple crossover pilot study. Clin Neuropharmacol 24:109–112
Zvartaui-Hind M, Din MU, Gilani A et al (2000) Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology 55:1587–1588
Fromm GH, Terrence CF, Chattha AS (1984) Baclofen in the treatment of trigeminal neuralgia: double blind study and long term follow-up. Ann Neurol 15:240–244
Kayser V, Aubel B, Hamon M, Bourgoin S (2002) The antimigraine 5-HT1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain. Br J Pharmacol 137:1287–1297
Tsui JK, Eisen A, Stoessl AJ et al (1986) Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 2:245–247
Difazio M, Jabbari B (2002) A focused review of the use of botulinum toxins for low back pain. Clin J Pain 18[Suppl 6]:S155–S162
Silberstein SD, Stark SR, Lucas SM et al; BoNTA-039 Study Group (2005) Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc 80:1126–1137
Piovesan EJ, Teive HG, Kowacs PA et al (2005) An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology 65:1306–1308
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
De Simone, R., Ranieri, A., Bilo, L. et al. Cranial neuralgias: from physiopathology to pharmacological treatment. Neurol Sci 29 (Suppl 1), 69–78 (2008). https://doi.org/10.1007/s10072-008-0892-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-008-0892-7